Product Overview
ID Components Size (96 tests)
ISK-020-1 High-bind Plate 1plate
ISK-020-2 Human IL-17RA 15μg
ISK-020-3 Biotinylated Human IL-17A 10μg
ISK-020-4 Anti-IL-17A Neutralizing Antibody 20μg
ISK-020-5 Streptavidin-HRP 10μg
ISK-020-6 Coating Buffer 12mL
ISK-020-C7 10xWashing Buffer 50mL
ISK-020-8 Blocking Buffer 50mL
ISK-020-9 Substrate Solution 12mL
ISK-020-10 Stop Solution 7mL
Description
Interleukin-17A (IL17A) is also known as cytotoxic T-lymphocyte-associated antigen 8 (CTLA8), which is a proinflammatory cytokine produced by activated T cells. IL17A can regulate the activities of NF-kappaB and mitogen-activated protein kinases. Also, IL17A can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). Furthermore, IL17A has been found both in glycosylated and nonglycosylated forms. High levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis.
Assay Principles
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new IL-17A pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human IL-17A to immobilized human IL-17 RA in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated IL-17A protein, a human IL-17 RA protein, an anti-IL-17A neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.
Your experiment will include 4 simple steps:
a) Coat the plate with human IL-17 RA.
b) Add your molecule of interest to the tests.
c) Add human IL-17A-Biotin to bind the coated IL-17 RA.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
Finally, the half maximal inhibitory concentration (IC50) of your compound to IL-17A: IL-17 RA binding will be determined by comparing OD readings among different experimental groups.